Fig. 1: Consort diagram.
From: A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
This figure summarizes the flux of patients in the study.
Fig. 1: Consort diagram. | Nature Communications
From: A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
This figure summarizes the flux of patients in the study.
